Literature DB >> 17597761

Non-transcriptional control of DNA replication by c-Myc.

David Dominguez-Sola1, Carol Y Ying, Carla Grandori, Luca Ruggiero, Brenden Chen, Muyang Li, Denise A Galloway, Wei Gu, Jean Gautier, Riccardo Dalla-Favera.   

Abstract

The c-Myc proto-oncogene encodes a transcription factor that is essential for cell growth and proliferation and is broadly implicated in tumorigenesis. However, the biological functions required by c-Myc to induce oncogenesis remain elusive. Here we show that c-Myc has a direct role in the control of DNA replication. c-Myc interacts with the pre-replicative complex and localizes to early sites of DNA synthesis. Depletion of c-Myc from mammalian (human and mouse) cells as well as from Xenopus cell-free extracts, which are devoid of RNA transcription, demonstrates a non-transcriptional role for c-Myc in the initiation of DNA replication. Overexpression of c-Myc causes increased replication origin activity with subsequent DNA damage and checkpoint activation. These findings identify a critical function of c-Myc in DNA replication and suggest a novel mechanism for its normal and oncogenic functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597761     DOI: 10.1038/nature05953

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  307 in total

Review 1.  Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Authors:  Anouchka Skoudy; Inmaculada Hernández-Muñoz; Pilar Navarro
Journal:  J Gastrointest Cancer       Date:  2011-06

2.  Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.

Authors:  Matilde Murga; Stefano Campaner; Andres J Lopez-Contreras; Luis I Toledo; Rebeca Soria; Maria F Montaña; Luana D' Artista; Thomas Schleker; Carmen Guerra; Elena Garcia; Mariano Barbacid; Manuel Hidalgo; Bruno Amati; Oscar Fernandez-Capetillo
Journal:  Nat Struct Mol Biol       Date:  2011-11-27       Impact factor: 15.369

Review 3.  Cdc6: a multi-functional molecular switch with critical role in carcinogenesis.

Authors:  Thodoris G Petrakis; Konstantinos Vougas; Vassilis G Gorgoulis
Journal:  Transcription       Date:  2012 May-Jun

4.  Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.

Authors:  Nikita Popov; Christina Schülein; Laura A Jaenicke; Martin Eilers
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

Review 5.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

6.  MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.

Authors:  Russell Moser; Masafumi Toyoshima; Kristin Robinson; Kay E Gurley; Heather L Howie; Jerry Davison; Martin Morgan; Christopher J Kemp; Carla Grandori
Journal:  Mol Cancer Res       Date:  2012-02-01       Impact factor: 5.852

7.  B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).

Authors:  Eugen Werwein; Thore Schmedt; Heiko Hoffmann; Clemens Usadel; Nora Obermann; Jeffrey D Singer; Karl-Heinz Klempnauer
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

8.  c-Myc interacts with TRF1/PIN2 and regulates telomere length.

Authors:  Hongtae Kim; Junjie Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-08-22       Impact factor: 3.575

Review 9.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

10.  DNA-protein interaction dynamics at the Lamin B2 replication origin.

Authors:  Luca Puzzi; Laura Marchetti; Fiorenzo A Peverali; Giuseppe Biamonti; Mauro Giacca
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.